ExonanoRNA

ExonanoRNA, LLC is a research-focused biotechnology company based in Columbus, Ohio. Founded in 2017, it is a small company with a team of three employees. With an annual revenue of $2.5 million, ExonanoRNA is focused on developing cutting-edge RNA nanotechnology solutions. The company specializes in the production of high-quality RNA nanoparticles for research and pre-clinical development. These nanoparticles have the unique ability to integrate multiple functional RNA modules, including scaffolds, ligands, therapeutic agents, and regulators, all composed primarily or exclusively of RNA. ExonanoRNA's core activities encompass research and development of innovative products in the field of RNA nanotechnology-based platforms. Their primary focus is on developing next-generation targeted drug delivery systems and advanced disease diagnosis tools. ExonanoRNA's team comprises experienced scientists dedicated to bridging the gap between laboratory research and clinical applications in bio-nanotechnology, particularly RNA nanotechnology. For more information about ExonanoRNA and its groundbreaking research, please visit their website at exonanorna.com.